Sign Up Today and Learn More About Shanghai Medicilon Stock
Invest in or calculate the value of your shares in Shanghai Medicilon or other pre-IPO companies through EquityZen's platform.
Shanghai Medicilon Stock
Medicilon has been recognized as one of the top drug discovery contract research organizations (CRO) in China
About Shanghai Medicilon Stock
Founded
2004
Industries
Science and Engineering, Health Care, Biotechnology
Shanghai Medicilon Press Mentions
Stay in the know about the latest news on Shanghai Medicilon
Drug Discovery Outsourcing Market size is set to grow by USD 1.79 bn from 2024-2028, robust demand for biosimilars ...
themalaysianreserve • May 21, 2024
[Top Players] of Ligand Binding Assay Market| Sygnature Discovery, Shanghai Medicilon Inc, Intertek Group plc
motionsonline • May 21, 2024
Cell Therapy CDMO Services Market Report | Shanghai Medicilon Biopharmaceutical Co., Ltd., Puxin Biomedicine
motionsonline • May 21, 2024
Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and development together
prnewswire • Jul 31, 2023
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division
prnewswire • Jul 12, 2023
Shanghai Medicilon Management
Leadership team at Shanghai Medicilon
CEO
Chunlin Chen Ph.D
Chief Executive Officer & Co-Founder
Chunlin Chen Ph.D
Join now and verify your accreditation status to gain access to:
- Shanghai Medicilon current valuation
- Shanghai Medicilon stock price
- Available deals in Shanghai Medicilon and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Shanghai Medicilon stock?
Accredited investors can buy pre-IPO stock in companies like Shanghai Medicilon through EquityZen funds. These investments are made available by existing Shanghai Medicilon shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Shanghai Medicilon stock?
Shareholders can sell their Shanghai Medicilon stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
